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Global Loss of Bmal1 Expression Alters Adipose Tissue
Hormones, Gene Expression and Glucose Metabolism
David John Kennaway*, Tamara Jayne Varcoe, Athena Voultsios, Michael James Boden
Robinson Institute, University of Adelaide, Adelaide, South Australia, Australia
Abstract
The close relationship between circadian rhythm disruption and poor metabolic status is becoming increasingly evident,
but role of adipokines is poorly understood. Here we investigated adipocyte function and the metabolic status of mice with
a global loss of the core clock gene Bmal1 fed either a normal or a high fat diet (22% by weight). Bmal1 null mice aged 2
months were killed across 24 hours and plasma adiponectin and leptin, and adipose tissue expression of Adipoq, Lep, Retn
and Nampt mRNA measured. Glucose, insulin and pyruvate tolerance tests were conducted and the expression of liver
glycolytic and gluconeogenic enzyme mRNA determined. Bmal1 null mice displayed a pattern of increased plasma
adiponectin and plasma leptin concentrations on both control and high fat diets. Bmal1 null male and female mice
displayed increased adiposity (1.8 fold and 2.3 fold respectively) on the normal diet, but the high fat diet did not exaggerate
these differences. Despite normal glucose and insulin tolerance, Bmal1 null mice had increased production of glucose from
pyruvate, implying increased liver gluconeogenesis. The Bmal1 null mice had arrhythmic clock gene expression in
epigonadal fat and liver, and loss of rhythmic transcription of a range of metabolic genes. Furthermore, the expression of
epigonadal fat Adipoq, Retn, Nampt, AdipoR1 and AdipoR2 and liver Pfkfb3 mRNA were down-regulated. These results show
for the first time that global loss of Bmal1, and the consequent arrhythmicity, results in compensatory changes in adipokines
involved in the cellular control of glucose metabolism.
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Introduction
The links between circadian rhythms of gene expression,
hormone secretion and metabolism have emerged over recent
years. For example glucose metabolism changes across the day and
night in humans [1,2], while studies in animals have shown that
ablation of the suprachiasmatic nucleus (SCN), the brain region
responsible for the entrainment of physiological systems to the
light/dark cycle, results in the loss of the rhythms of glucose
tolerance [3]. Bmal1 (also known as Mop3 or Arntl1) [4] and Clock
[5] are recognised as critical components of cellular circadian
rhythm generation. The BMAL1/CLOCK heterodimeric protein
induces other clock genes (e.g., Per1, Per2, Cry1, Cry2, Nr1d1) upon
binding to E-box elements in the promoters of the genes. After
complexing with Casein kinase 1e/d, the PER/CRY/Casein
kinase complex returns to the nucleus and inhibits the action of
BMAL1/CLOCK, thus reducing the expression of the period and
cryptochrome genes. NR1D1 plays an important role in the
generation of rhythmicity through its repression of Bmal1
expression. We [6,7] and others [8–11] have shown that disruption
of endogenous cellular rhythmicity via mutation of Clock is
associated with alterations in metabolism. The ClockD19 mutants
produce a protein that can bind to BMAL1, but not induce gene
expression, resulting in a loss of rhythmic gene expression in
peripheral tissues, but not the SCN [12]. This mutation has been
shown to be associated with obesity [10], hyperinsulinaemia [10],
decreased glucose tolerance [7,11], increased insulin sensitivity
[7,11], hyper-lipidaemia, and decreased plasma free fatty acids [7].
The mutant phenotype does, however, depend upon the
background strain of the mice studied. It is known that some of
the functions of Clock in certain tissues (e.g., brain) are rescued in
ClockD19 mutant mice and Clock null mice by a homologue, Npas2
[13–15]. The metabolic consequences of global rhythm disruption
have been studied by several laboratories, but there are still large
gaps in our knowledge. The best candidate for investigating global
arrhythmia is the Bmal1 null mouse, originally produced by the
Bradfield laboratory [4], with another line reported recently in
Japan [16]. Unlike ClockD19 mutant or Clock null mice, Bmal1 null
mice have poorly entrained wheel running behaviour under a
normal photoperiod and are arrhythmic in continuous darkness
[4]. Moreover, there is no evidence that Bmal2 rescues the
functions of Bmal1 in the Bmal1 null mouse [4,17]. Interestingly
Bmal1 null mice are infertile [18,19] and as they age, develop a
range of physiological deficits including arthropathy [20] and
altered cardiovascular function [21].
In this study we report for the first time the effects of loss of
Bmal1 expression on plasma adipokine levels (adiponectin and
leptin) and adipose tissue expression of adiponectin (Adipoq), leptin
(Lep), resistin (Retn) and visfatin (Nampt) mRNA in young animals (2
months of age), before any confounding pathology was likely to
emerge. In addition we report the effects of global loss of Bmal1
expression on glucose, insulin and pyruvate tolerance tests and
expression of liver glycolytic and gluconeogenic enzyme mRNA.
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Finally we investigated the metabolic impact of a high fat diet on
body and adipose tissue weight, plasma metabolites, insulin and
adipokines in Bmal1 null mice.
Methods
The founder Bmal1 null mice [4] were generously provided by
Dr C Bradfield (University of Wisconsin Medical School,
Madison, WI, USA) and were subsequently maintained as a
heterozygous line on the original mixed background (C57Bl/6 and
129/SV). The study was approved by the Animal Ethics
Committee of the University of Adelaide. Animals were main-
tained on a 12 h light:12 h darkness photoperiod (lights off at
2000 h) in the University of Adelaide Medical School Specific
Pathogen Free Animal House, and were provided with the control
diet of standard mouse chow (7% fat (wt/wt), Ridley AgriProducts,
Melbourne, Australia) and water ad libitum. The genotypes of the
offspring were determined as previously described by PCR of tail
DNA [4].
Groups of Bmal1 null male mice and their wild-type litter mate
controls (4 mice per time point) were killed by decapitation at 2
months of age every four hours across 24 hours at 0800 h, 1200 h,
1600 h, 2000 h, 2400 h and 0400 h. Blood was collected into
heparinised tubes and plasma harvested for metabolite and
hormone assays. Liver and epigonadal fat were rapidly dissected
and immediately placed in RNAlaterH (Ambion, Austin, TX) and
then stored at 220uC until processing. An additional group of 6
month old male Bmal1 null and wild-type mice (4–9 mice per time
point) were killed at the same times of day and blood collected.
To determine the effects of a high-fat diet on plasma hormones
and metabolites, male and female Bmal1 null and wild-type mice
were fed a high-fat diet (22% fat (wt/wt), 0.15% cholesterol,
4.6 kcal/g, SF00-219, Specialty Feeds, Glen Forrest, Western
Australia) or the control diet from 3 to 8 weeks of age (n = 10–
19 mice of each sex per genotype). Animals were weighed and
killed during the mid light period (1400 h), trunk blood collected
and the epigonadal/retroperitoneal fat pads, testes/uteri and
kidneys were dissected and weighed.
Intraperitoneal Glucose Tolerance Test
Wild-type and Bmal1 null male mice aged 2 and 6 months
(n = 5–6) were maintained on the control diet, fasted overnight and
injected with glucose (1 mg/g body weight; i.p.; Sigma Chemical,
St Louis, MO) starting 2 h after the lights were turned on as
previously described [7]. Blood was obtained from the tail vein
before and 30 and 60 minutes after glucose administration for the
determination of blood glucose.
Intraperitoneal Pyruvate Tolerance Test
Wild-type and Bmal1 null 2 month old male mice (n = 6) and
female mice (n = 5–7) were maintained on the control diet, fasted
overnight and injected with sodium pyruvate (2 mg/g body
weight; i.p.; Sigma Chemical, St Louis, MO) starting 2 h after the
lights were turned on as previously described [22]. Blood was
obtained from the tail vein before and 15, 30, 60, 90, 120 minutes
after pyruvate administration for the determination of blood
glucose.
Intraperitoneal Insulin Tolerance Test
Wild-type and Bmal1 null male and female mice (n = 6 per
gender) aged 2 months were maintained on the control diet and
had food withheld for 2 hours before injection of insulin (0.75 IU/
kg body weight; Actrapid; Novo Nordisk Pharmaceuticals Pty.
Ltd., Baulkham Hills, Australia) 2–3 h after lights on as previously
described [7]. Blood was obtained from the tail vein before and 30,
60, 90 and 120 minutes after insulin administration for the
determination of blood glucose.
Real-time RT-PCR
To investigate the expression of clock and clock controlled genes
in the liver and adipose tissue total mRNA was extracted, reverse
transcribed and amplified by real time PCR. Some of the primers
have been used previously by our group [6,13], but for
completeness all primers used have been listed in Table 1. The
calibrator sample was designated as the most highly expressed time
point for each gene of interest in the wild-type mice and given a
relative expression of 1.
Hormone and Metabolite Assays
Plasma glucose and free fatty acids were measured enzymat-
ically [7]. Plasma triglycerides were measured with a Hitachi
912 automated sample system using a kit as per the
manufacturer’s instructions (Roche Diagnostics, Australia). Plas-
ma insulin, adiponectin and leptin were assayed by radioim-
munoassay [7].
Statistics
Hormone, body weight, organ weight and gene expression data
were analyzed by univariate ANOVA (SPSS v17), using genotype
and time of day as the dependent variables followed by post hoc
analysis using the Bonferroni correction for multiple comparisons.
For the body composition, hormone and gene expression data
collected across 24 h, the Estimated Marginal Means are reported
in the text for the various comparisons. To determine whether
hormone and gene expression data were rhythmic, i.e., fitted a
sine curve, the data were analyzed using CircWaveBatch; http://
hutlab.nl/[23].
Results
Plasma Glucose, Free Fatty Acids and Hormones
Plasma glucose and free fatty acids were not different
between wild-type and Bmal1 null mice, however, plasma
insulin was lower (P,0.02) and adiponectin (P,0.001) and
leptin (P,0.001) were higher in Bmal1 null compared to wild-
type mice (Fig. 1).
Similar differences in plasma insulin and adipokines between
Bmal1 null mice and wild-type mice were observed in 6 month old
mice. In particular the Bmal1 null mice had lower plasma insulin
(1.0260.12 ng/ml in wild-type mice vs. 0.3160.12 ng/ml in
Bmal1 null mice), higher adiponectin (5.960.8 mg/ml in wild-type
mice vs.15.760.8 mg/ml in Bmal1 null mice) and higher leptin
(0.860.1 ng/ml in wild-type mice vs. 2.860.2 ng/ml in Bmal1
null mice) than wild-type mice.
In summary, across 24 hours, plasma insulin was lower and
adiponectin and leptin were both higher in 2 month old male
Bmal1 null mice compared to wild-type mice while plasma glucose
and free fatty acids were unchanged. These differences persisted in
6 month old mice.
Intraperitoneal Glucose Tolerance Tests
At 2 and 6 months of age, male Bmal1 null and wild-type mice
had similar fasting blood glucose (data not shown). The peak
glucose levels and area under the curve during the glucose
tolerance tests in wild-type and Bmal1 null mice at 2 and 6 months
of age were not different (data not shown).
Adipokines in Bmal1 Null Mutants
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Intraperitoneal Insulin Tolerance Tests
At 2 months of age, male Bmal1 null mice had a trend to
decreased blood glucose (P= 0.06; Fig. S1) prior to the insulin
injection, but the subsequent decrease was similar for the wild-type
and Bmal1 null mice. Furthermore, both groups had a similar
counter-regulatory rebound of blood glucose. Similarly there was
no difference in the glucose response to insulin in female wild-type
and Bmal1 null mice.
Intraperitoneal Pyruvate Tolerance Tests
At 2 months of age, administration of pyruvate resulted in
increased blood glucose levels in both male and female Bmal1 null
mice compared to wild type mice (Fig. 2). The blood glucose levels
failed to return to the baseline within 120 minutes in either the
wild-type or Bmal1 null mice, but was significantly higher at 120
minutes post injection in Bmal1 null mice compared to wild-type
mice males (P,0.05), but not females.
Effect of a High Fat Diet on Body Weight and Fat Depots
Following five weeks on the control diet, body weight of the
male Bmal1 null mice were 14% lower than wild-type mice
(P,0.005). On the high fat diet, male Bmal1 null mice gained
weight such that they were no longer lighter than wild type mice
(Fig. 3). Wild type mice had increased epididymal and retroper-
itoneal fat pads when placed on a high fat diet (P,0.001), while in
the Bmal1 null mice only the epididymal fat pads were increased
for animals on the high fat diet (P,0.001). Male Bmal1 null mice
had 58% and 52% more epigonadal fat and 182% and 64% more





Number Primers Amplicon Length
b-actin b-actin NM031144 F CCTCTGAACCCTAAGGCCAA 90 bp
R AGCCTGGATGGCTACGTACA
Adiponectin Adipoq NM_009605 F TGTTGGAATGACAGGAGCTGAA 104 bp
R CACTGAACGCTGAGCGATACA
Adiponectin receptor 1 AdipoR1 NM_028320 F GGAGGGACGTTGGAGAGTCAT 105 bp
R GCCCGAAAGGAGGGCATA
Adiponectin receptor 2 AdipoR2 NM_197985 F GCTCCTACAGGCCCATCATG 103 bp
R CCAATCCGGTAGCACATCGT
Bmal1 Bmal1 AB015203 F GTCGAATGATTGCCGAGGAA 101 bp
R GGGAGGCGTACTTGTGATGTTC
Fructose-1,6-bisphosphatase 1 Fbp1 NM_019395 F CCCGTCCATTGGAGAATTCAT 101 bp
R GGTCAAAGTCCTTGGCATAACC
Glucokinase Gck NM_010292 F TTTGTGTCGCAGGTGGAGAG 102 bp
R CACAATGTCGCAGTCGGC
Glucose-6-phosphatase G6pc NM_008061 F CTTAAAGAGACTGTGGGCATCAA 101 bp
R AATACGGGCGTTGTCCAAAC
Leptin Lep NM_008493 F CAGCCTGCCTTCCCAAAA 137 bp
R CATCCAGGCTCTCTGGCTTCT
Nuclear receptor subfamily 1,
group D, member 1 (Rev erb a)
Nr1d1 NM_145434 F TCCAGTACAAACGGTGTCTGAA 101 bp
R GCCAACGGAGAGACACTTCTTG












Pck1 NM_011044 F GTTCCCAGGGTGCATGAAAG 107 bp
R AGGGCGAGTCTGTCAGTTCAA
Resistin Retn NM_022984 F CCTTTTCTTCCTTGTCCCTGAA 101 bp
R ACAGGGAGTTGAAGTCTTGTTTGAT
Visfatin Nampt NM_021524 F TTTTGAACACATAGTAACACAGTTCTCATC 101 bp
R GGTCTTCACCCCATATTTTCTCA
doi:10.1371/journal.pone.0065255.t001
Adipokines in Bmal1 Null Mutants
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retroperitoneal fat per gram of body weight than wild-type mice
maintained on the normal chow and high fat diet respectively
(P,0.001). When the epigonadal and retroperitoneal fad pad
weights were combined, male Bmal1 null mice had 1.8 fold more
fat than the wild-type mice on the chow diet and 1.5 fold more
when on the high fat diet. Testes weight in male Bmal1 null mice
were reduced compared to the wild type mice only when
maintained on the chow diet (P,0.001) and kidney weight in
the Bmal1 null males was reduced compared to wild type on both
diets (P,0.01).
Body weights of female Bmal1 null mice on a high fat diet were
increased when compared to chow fed Bmal1 females and wild
type females placed on a high fat diet (Fig. 3, P,0.01). Female
Bmal1 null mice had 141% and 117% more epigonadal fat per
gram of body weight than wild-type mice maintained on the
normal chow and high fat diet respectively (P,0.001). Bmal1 null
mice on a high fat diet had more retroperitoneal fat compared to
high fat diet wild type mice (P,0.001) and there was a trend for
increased adiposity compared to wild type for Bmal1 null mice on a
chow diet and when comparing Bmal1 null females on a high fat vs
chow diet (P = 0.016 and P= 0.014 respectively). When the
epigonadal and retroperitoneal fad pad weights were combined,
female Bmal1 null mice had 2.3 fold more fat than the wild-type
mice on the chow diet and 2.3 fold more when on the high fat diet.
While showing a trend to smaller uteri in chow fed animals
(P = 0.018), female Bmal1 null mice uteri were not lighter than
wild-type mice maintained on the normal chow or high fat diet
(P.0.05), nor were kidney weights effected.
In summary, male Bmal1 null mice weighed less than wild-type
mice when maintained on the chow diet but caught up when
placed on the high fat diet, whereas female Bmal1 null mice had
Figure 1. Plasma metabolites, insulin, and adipokines in
8 week old wild-type and Bmal1 null mice. Plasma glucose (a),
free fatty acids (b), insulin (c), adiponectin (d) and leptin (e) levels. Data
are the mean 6 s.e.m. for n= 4 mice of each genotype at each time
point, wild-type mice (open circles) and Bmal1 null mice (closed circles).
The accompanying histograms represent the estimated marginal means
6 s.e.m. of the individual gene expression as calculated from the
ANOVA. The shaded areas represent the period of darkness. The symbol
* indicates that there was a significant difference (P,0.05) between the
genotypes.
doi:10.1371/journal.pone.0065255.g001
Figure 2. The blood glucose response to the intra peritoneal
administration of pyruvate (2 mg/g) to male and female wild-
type and Bmal1 null mice fed a normal rodent diet. The mean 6
s.e.m. plasma glucose levels are shown for male (a) and female (c) wild-
type (open circles) and Bmal1 null (closed circles) mice. The mean area
under the curve (6 SEM) of the plasma glucose profiles up to 120 min
post injection (b, d).
doi:10.1371/journal.pone.0065255.g002
Adipokines in Bmal1 Null Mutants
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comparable body weight on a normal chow diet, but weighed
more when maintained on a high fat diet compared to chow fed
Bmal1 null mice or high fat fed wild type mice. For both control
and high fat diets, Bmal1 null male and female mice had a greater
degree of adiposity than wild type mice.
Effect of a High Fat Diet on Plasma Metabolites and
Hormones at Mid-light
When the male mice were killed at mid-light (1400 h), there was
no difference in plasma glucose, free fatty acids and insulin
between wild-type and Bmal1 null mice, however, plasma
triglyceride (78% and 72%) and adiponectin (91% and 51%)
were increased in Bmal1 null mice on chow diet and high fat diet
respectively (Fig. 4; P,0.01). The high fat diet did not affect
plasma glucose, triglyceride or adiponectin, but increased circu-
lating NEFA (by 70%) and insulin (by 165%) in the wild type mice.
Plasma leptin was increased in Bmal1 compared to wild types on
chow diet, and between chow and high fat fed wild type mice
(P,0.001).
When the female mice were killed at mid-light (1400 h), there
was no difference in plasma glucose, NEFA and insulin between
wild-type and Bmal1 null mice, however adiponectin (by 63%) and
leptin (by 56%) were increased in Bmal1 null mice on chow diet,
and plasma triglyceride was increased in Bmal1 null mice on both
chow (33%) and high fat diets (by 33% and 60% respectively,
P,0.01). The high fat diet did not affect plasma glucose,
triglyceride or adiponectin, but increased NEFA in the wild type
(72%) and Bmal1 null mice (38%), increased circulating insulin by
77% in wild type mice and increased circulating leptin in both wild
type and Bmal1 null mice (139% and 108% respectively, P,0.01).
Epigonadal Fat Gene Expression
In the epigonadal fat, overall expression of Per2 (230%), Pparc
(24%), Nr1d1 (298%), Adipoq (231%), Retn (229%), Nampt
(252%), Adipor1 (216%) and Adipor2 (235%) mRNA was
decreased (P,0.05), but Lep mRNA was unchanged (P.0.05) in
male Bmal1 null mice compared to the wild-type mice (Fig. 5).
Expression of Bmal1, Per2, Pparc, Nr1d1, Adipoq, Lep, Adipor1 and
Adipor2 mRNA was rhythmic in wild-type mice (fitted significantly
to a sine curve), but Retn and Nampt mRNA expression was
arrhythmic. Expression of all genes analysed in male Bmal1 null
mice was arrhythmic except for Lep mRNA (P,0.05).
Liver Gene Expression
In the liver overall Per2, Pck1 (phosphoenolpyruvate carboxykinase 1),
Fbp1 (fructose-1,6-bisphosphatase 1), G6pc (glucose-6-phospha-
tase ), Gck (glucokinase) and Adipor2 mRNA expression did not vary
with genotype, whereas Pfkfb3 (6-phosphofructo-2-kinase/fruc-
tose-2,6-biphosphatase 3) mRNA was decreased by 25% in male
Bmal1 null mice compared to wild type mice (Fig. 6; P,0.05).
Bmal1, Per2, Pfkfb3, Pck1, Fbp1 and Gck mRNA was expressed
rhythmically in the wild type mice (P,0.05), whereas G6pc and
Adipor2 mRNA expression was arrhythmic. Expression of all
genes analysed in male Bmal1 null mice was arrhythmic.
The gene expression levels for the genes involved in the
glycolysis and gluconeogenesis pathways (Gck, Pck1, Pfkfb3, Fbp1
and G6pc) were also analysed (ANOVA) using only the 0800 h and
1200 h time points (light period), the time around which the
glucose and insulin tolerance tests were performed. In contrast to
the 24 hour analysis, expression of Gck and G6pc were increased
1.7 fold (P= 0.05) and 1.6 fold (P= 0.09) respectively in Bmal1 null
mice at these times.
In summary, across 24 hours, Pfkfb3 mRNA was decreased, but
expression of Per2, Gck, Pck1, Fbp1, G6pc and Adipor2 mRNA was
unchanged. Expression of Gck and G6pc mRNA was increased
during the early light period. The rhythm of expression of Per2,
Pfkfb3, Pck1, Fbp1 and Gck mRNA evident in wild-type mice was
absent in male Bmal1 null mice.
Discussion
In this study we show for the first time that global disruption of
gene rhythmicity in both male and female Bmal1 null mice alters
plasma levels of adiponectin and leptin and adipokine gene
expression (Adipoq, Nampt and Retn mRNA). At 2 and 6 months of
age, plasma adiponectin and leptin were higher in Bmal1 null mice
than wild-type mice. Although tending to weigh less than the wild-
type mice, Bmal1 null mice had a greater degree of adiposity
(1.8 fold and 2.3 fold more fat in males and females respectively).
Adipoq, Nampt and Retn mRNA expression was reduced in Bmal1 null
compared to the wild-type mice, but their increased adiposity is
consistent with the increased secretion of these adipokines. We
were not able to measure plasma resistin or visfatin in this study
due to the limited volume of plasma available for assay.
The ‘‘Western diet’’ (containing 22% fat and 0.15% cholesterol)
used in this study was chosen as we wished to challenge the
homeostasis of the Bmal1 null mice and observe initial stages of loss
of metabolic control, which may have been obscured with a more
extreme and less physiological diet. When the mice were fed the
diet for 5 weeks, the differences in adiposity between the Bmal1
null and wild-type mice was maintained but not increased,
suggesting the Bmal1 null mice are not more sensitive to this
metabolic challenge. There was a pattern towards a small increase
in body weight in Bmal1 null mice in response to 5 weeks on the
high fat diet, with minimal change in the wild type mice. This was
not unexpected given the moderate challenge of the diet, however
both Bmal1 null and wild type mice increased their adiposity by
approximately 50%. Both lines showed signs of increasing their
plasma free fatty acids and leptin to a similar extent on the diet. In
previous studies, the body weight of comparable age Bmal1 null
mice has been reported as normal [24,25], increased [26] or
decreased [16,27,28]. Similarly the increased adiposity observed
here has been reported previously in some studies, [24,26,28], but
not by others [4,16,29].
In this study, plasma insulin (calculated across 24 hours) was
decreased in male Bmal1 null mice at 2 and 6 months of age, which
is consistent with the decreased glucose stimulated insulin section
reported by 3 independent groups [11,16,25]. Accompanying the
secretory defect, glucose intolerance was reported in 2 studies
[11,25] while in another study there was decreased plasma insulin
and increased glucose tolerance [24]. We observed neither glucose
intolerance nor altered whole body insulin sensitivity in Bmal1 null
mice. A possible explanation for the normal glucose despite
decreased insulin secretion in Bmal1 null mice may relate to the
elevated plasma adiponectin which is known to be an insulin
sensitising adipokine [30]. In previous studies in our laboratory we
Figure 3. The body composition of male and female wild-type and Bmal1 null mice fed either normal rodent chow or a high fat diet
(22% fat). The data are the means (grams or grams per 20 grams body weight 6 s.e.m.; n= 13–19 mice per group). Body weight (a, b), epigonadal
fat pad (c, d), retroperitoneal fat pad (e, f), testis/uterus (g, h) and kidney (i, j). Males (a, c, e, g, i); females (b, d, f, h, j). Bars above the histogram define
the difference between the groups with significant difference set to P,0.0125.
doi:10.1371/journal.pone.0065255.g003
Adipokines in Bmal1 Null Mutants
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found that Clock D19+MEL mutant mice [12] had low/normal
plasma glucose and insulin, but were glucose intolerant and insulin
sensitive [7]. They also had elevated plasma adiponectin levels and
Adipoq mRNA expression, but unlike the Bmal1 null mice, did not
show increased adiposity [6]. We hypothesise that both the Clock
D19+MEL mutant and Bmal1 null mice have adapted to a
pancreatic insulin secretory defect by altering the levels of
adipokines that modulate insulin sensitivity (adiponectin), to
maintain glucose homeostasis. Interestingly, Clock D19+MEL
mutant mice had low plasma free fatty acids [7] which would
also be expected to improve insulin sensitivity, but Bmal1 null mice
did not exhibit this phenotype.
Bmal1 null mice did not express Per2 mRNA rhythmically in the
liver in contrast to the wild-type mice. These results confirm the
original observations, that disruption of Bmal1 interferes with
circadian rhythm generation [4]. Expression of several of the genes
for enzymes involved in glycolysis and gluconeogenesis (Pfkfb3, Pck,
Fbp1, and Gck) were rhythmic in wild-type, but not Bmal1 null
mice. When analysed across 24 hours, the overall expression of
these genes was not altered, except for Pfkfb3 mRNA expression,
which was reduced. Expression of Pck and Fbp1 mRNA prior to
darkness was clearly reduced in the Bmal1 null mice, perhaps
reflecting a change in feeding pattern caused by the loss of
rhythmicity.
The observation in the current study that Bmal1 null mice have
increased pyruvate tolerance was unexpected because a previous
study reported that the loss of Bmal1 resulted in decreased pyruvate
tolerance when the test was conducted 7 hours after expected
lights on (ZT7) [9]. No measurements of either the expression of
genes involved in gluconeogenesis or enzyme activity were
reported and it was not clear what control strain was used.
Nevertheless it was concluded that gluconeogenesis was abolished
by deletion of Bmal1. More recently Shimba et al. [16] reported
that the peak blood glucose level was significantly higher and the
clearance was slower in Bmal1 null mice, as compared to those in
control mice following a pyruvate challenge test, similar to that
observed here. However, Shimba et al. [16] reported that the
expression of G6pc and Fbp mRNA in the liver was increased in the
Bmal1 null mice and that liver glucose-6 phosphate was
significantly higher than that of control mice, whereas we found
the overall 24 hour expression of Pfkfb3 mRNA to be lower in the
Bmal1 null mice, particularly during the 4 hours before lights off.
This discrepancy may be explained by the fact that in the Shimba
et al. study [16] the gene analyses were conducted on animals that
had been fasted for 16 hours prior to tissue collection at ZT10 (2
hours before lights off). In the current study, we collected livers at
6 time points over 24 hours from animals fed ad libitum. We found
a trend (P= 0.09; 2-way ANOVA) for higher G6pc mRNA
expression in the livers of Bmal1 null mice at 0800 h and
1200 h, the time at which the pyruvate tolerance tests were
conducted. Thus these results may explain the increase in glucose
conversion in male and female Bmal1 null mice over the wild type
mice. The failure of the gene expression data to reach significance
in the sub analysis of the 0800 h and 1200 h time points probably
reflects the lower power. Future studies on the impact of loss of
Bmal1 on gluconeogenesis should carefully control the time of day
and feed access that the analyses are conducted and in addition
assess possible changes in enzyme activity.
The observation of increased adiposity in Bmal1 null mice on
normal chow confirms 3 recent reports [16,24,28]. While this may
be considered confirmatory evidence that disrupted circadian
rhythmicity results in obesity as previously hypothesised on the
basis of a study in Clock D19 (C57Bl/6) mice [10], there are some
caveats to be considered. First the Clock D19+MEL mice [12] which
are on a CBA background do not have an obese phenotype nor do
they become disproportionately fat when fed a high fat diet [6].
Second, the adipokine profile of the Bmal1 null mice is not typical
since both adiponectin and leptin are elevated. In the case of Clock
Figure 4. The plasma metabolites and adipokines of male and
female wild-type and Bmal1 null mice fed either normal rodent
chow or a high fat diet. The data are the means 6 s.e.m. (n= 9–
19 mice per group). Plasma glucose (a, b), triglycerides (c, d), free fatty
acids (e, f), insulin (g, h), adiponectin (i, j) and leptin (k, l) levels. Males (a,
c, e, g, i); females (b, d, f, h, j). Bars above the histogram define the
difference between the groups with significant difference set to
P,0.0125.
doi:10.1371/journal.pone.0065255.g004
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Figure 5. The relative gene expression across 24 h of clock and other genes in the epigonadal adipose tissue of male wild-type and
Bmal1 null mice fed a normal rodent diet. (a) Bmal1, (b) Per2, (c) Pparc, (d) Nr1d1, (e) Adipoq, (f) Lep (g) Retn, (h) Nampt (i) Adipor1 and (j) Adipor2.
The data are the relative expression for each gene compared to Actin mRNA (mean 6 s.e.m., n = 4 for each genotype), wild-type mice (open circles)
and Bmal1 null mice (closed circles). The highest expression of each gene for wild-type mice was set at one. The apparent absence of an SEM bar
indicates that it is obscured by the symbol. The shaded areas represent the period of darkness.
doi:10.1371/journal.pone.0065255.g005
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D19+MEL mice, adiponectin is elevated but not leptin [6].
Adiponectin is normally low and leptin high in obese rodent
models. There was no change in adiponectin receptor mRNA
expression in liver, but both Adipor1 and Adipor2 mRNA expression
was decreased in epigonadal fat. This suggests that there are
important modifications in adipose tissue that develop in the
absence of Bmal1 or disrupted clock function when the defect is
present throughout life. Interestingly, the size of the adipocytes in
the wild-type and Bmal1 null mice were not different (data not
shown), suggesting that the lack of Bmal1 potentiated adipogenesis.
In the current study we identified a profound decrease in Nr1d1
mRNA expression in the epigonadal fat pads in Bmal1 null mice. It
is well established that CLOCK/BMAL1 heterodimers induce
Nr1d1 mRNA through interactions at an E-box on the promoter
[31]. Loss of either Clock or Bmal1 will reduce Nr1d1 mRNA
expression and eliminate its rhythmicity. Adipogenesis is char-
Figure 6. The relative gene expression across 24 h of clock and liver enzyme genes in the liver of male wild-type and Bmal1 null
mice fed a normal rodent diet. (a) Bmal1, (b) Per2, (c) Pfkfb3, (d) Pck, (e) Fbp1, (f) G6pc, (g) Gck and (h) Adipor2. The data are the relative expression
for each gene compared to Actin mRNA (mean 6 s.e.m., n = 4 for each genotype), wild-type mice (open circles) and Bmal1 null mice (closed circles).
The highest expression of each gene for wild-type mice was set at one. The apparent absence of an SEM bar indicates that it is obscured by the
symbol. The shaded areas represent the period of darkness.
doi:10.1371/journal.pone.0065255.g006
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acterised by high Nr1d1 mRNA expression [32,33] and Nr1d1
mRNA is induced by PPARc [34]. In Bmal1 null mice, loss of
rhythmic Nr1d1 resulted in arrhythmic Pparc expression but levels
of Pparc mRNA remained around the circadian nadir levels. The
high degree of adiposity in Bmal1 null mice would therefore
suggest that low constitutive expression of Nr1d1 may be sufficient
to allow adipogenesis and that its rhythmicity is not critical or that
the lipolytic pathways in Bmal1 null mice are also significantly
downregulated.
The metabolic phenotype of Bmal1 null mice is different from
that found in Clock D19 mutant mice on either C57Bl/6 [10], IRC
[8,35,36] or CBA [7] backgrounds. The metabolic phenotype of
ClockD19 mutants is one of obesity, hyper-insulinaemia, hyper-
lipidaemia, glucose intolerance and increased insulin sensitivity
[6,7,10,11], although not all metabolic alterations are observed in
mutants on all backgrounds. In the current study we used Bmal1
null mice that were maintained on a mixed background because
we did not wish to confound the impact of Bmal1 loss with other
metabolically important mutations present in inbred strains like
the C57/Bl6 mice [37]. We expected that the metabolic
consequences for global Bmal1 null mice with a complete lack of
central and peripheral rhythmicity would be exacerbated over and
above those observed in Clock D19 mutants. Bmal1 null mice do not,
however, show evidence of a major metabolic disorder. This is not
to say that Bmal1 null mice are normal, since they have a reduced
life expectancy [29], are prone to develop arthropathies [20] and
are infertile [18,19]. At least while they are maintained on ad
libitum feeding, Bmal1 null mice appear able to maintain normo-
glycaemia, despite hypertriglyceridaemia, hyperlipidaemia and
hyperleptinaemia. Interestingly despite this potential cardiovascu-
lar risk, Bmal1 null mice have recently been shown to be
hypotensive and have lower stress induced alterations in blood
pressure [21]. As in many other genetic animal models, Bmal1 null
mice appear to have compensated for the long term lack of Bmal1
and/or rhythmicity by altering a range of physiological systems
including adipose tissue growth, adipokine secretion and feeding
behaviour to maintain glucose homeostasis.
Our analyses of the metabolic parameters of the Bmal1 null
model do not discriminate between that caused by arrhythmicity
and any non-circadian functions of this gene. Nevertheless, there is
mounting evidence for a role of circadian rhythms in the
regulation of metabolic function, as demonstrated through a
variety of knock out and mutant mice models. Furthermore, from
our results, it is clear that removal of the Bmal1 gene leads to
cellular arrhythmicity of not only clock genes, but also genes
involved in key metabolic processes including adipogenesis and
gluconeogenesis. We believe therefore, that it is this circadian
arrhythmicity, at both the cellular and whole organism level, that
leads to the metabolic perturbations observed here, rather than
any non-clock function of Bmal1.
In summary, global loss of Bmal1, and the circadian arrhythmi-
city this creates, leads to increased adiposity when maintained on
both control and high fat diets. Furthermore, the Bmal1 null mice
displayed increased plasma adiponectin and leptin levels, despite
reduced or normal expression of Adipoq and Lep mRNA
respectively. Presumably the 1.8–2.3 fold increase in adiposity,
and hence the greater number of fat cells available for secretion of
these hormones, plays a role in the elevated concentrations in
plasma. Bmal1 null mice also displayed an elevated response to
pyruvate challenge, which when considered with the normal
glucose and insulin tolerance, suggest an increased capacity for
gluconeogenesis. Nevertheless, Bmal1 null mice display normal
profiles of plasma glucose. Finally the loss of adipocyte and hepatic
rhythmic gene expression and down-regulation of key metabolic
genes in both tissues emphasises further the regulatory role Bmal1
is able to play. Together these results demonstrate that disrupted
circadian rhythmicity leads to changes in adipocyte function and
compensatory changes in adipokines involved in the cellular
control of glucose metabolism, and provides further support for
the role of circadian rhythms in the regulation of metabolic
homeostasis.
Supporting Information
Figure S1 Blood glucose response to intraperitoneal
administration of insulin. Insulin (0.75 IU/kg) was injected
into wild-type (open circle) and Bmal1 null (closed circle) mice and
blood glucose measured over the subsequent 2 hours. Data are
mean 6 SEM (n=6); (a) males, (b) females.
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